Author: Cedar Park Staff

Analyst Activity Update on MEI Pharma, Inc. (NASDAQ:MEIP)

Research brokerage firms on Wall Street are offering a consensus “Buy” rating on shares of MEI Pharma, Inc. (NASDAQ:MEIP).  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.40 on the shares.  Based on a recent […]